SCHEMBL6972075

SCHEMBL6972075

COc1cc(Nc2nccc(NC(=O)c3ccccc3)n2)cc(OC)c1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 8/20 0.64
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
EGFR P00533 3/20 0.58
KDR P35968 2/20 0.58
INSR P06213 1/20 0.58
MET P08581 1/20 0.58
CDK2 P24941 1/20 0.58
TEK Q02763 1/20 0.58
ATM Q13315 1/20 0.57
BTK Q06187 1/20 0.55
PRKCA P17252 2/20 0.54
PRKD3 O94806 1/20 0.54
PRKCG P05129 1/20 0.54
PRKCB P05771 1/20 0.54
LCK P06239 1/20 0.54
PRKCH P24723 1/20 0.54
PRKCI P41743 1/20 0.54
ZAP70 P43403 1/20 0.54
PRKCE Q02156 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28160275 0.84 IGF1R (0.62) IGF1REGFRKDRINSRMET
SCHEMBL6981464 0.82 IGF1R (0.78) IGF1RMEN1KMT2AEGFRKDR
SCHEMBL6977468 0.82 IGF1R (0.57) IGF1REGFRKDRINSRMET
SCHEMBL5549011 0.81 SMN1; SMN2 (0.61) IGF1RMEN1KMT2AEGFRKDR
SCHEMBL1116462 0.80 IGF1R (0.79) IGF1RMEN1KMT2AEGFRKDR
SCHEMBL6978356 0.80 IGF1R (0.57) IGF1REGFRKDRINSRMET
SCHEMBL4349785 0.79 MEN1 (0.60) MEN1KMT2AATM
SCHEMBL17545196 0.79 PTK2 (0.76) IGF1RAURKAPTK2
SCHEMBL6979115 0.78 FAM20C (0.70) IGF1REGFRKDRINSRMET
SCHEMBL30958899 0.78 ATM (0.89) MEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862560-B1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 2003-04-02 EP disclosed
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 US disclosed